Literature DB >> 14747002

Genetics of multiple sclerosis.

David A Dyment1, George C Ebers, A Dessa Sadovnick.   

Abstract

Multiple sclerosis (MS) is probably aetiologically heterogeneous. Systematic genetic epidemiological and molecular genetic studies have provided important insights. Both genetic and non-genetic (environment, stochastic) factors may be involved in susceptibility as well as outcome, but we have yet to understand their relative roles. Any environmental factor is likely to be ubiquitous and act on a population-basis rather than within the family microenvironment. Taken together, the results of genome screening studies provide strong evidence for exclusion of a major locus in MS. There are, however, many genes that seem to be associated with MS. These include, but are in no way limited to, HLA classes I and II, T-cell receptor beta, CTLA4, ICAM1, and SH2D2A. The future of MS genetics, as for most common complex disorders, will be dependent on the resources available, ranging from biological samples and comprehensive databases of clinical and epidemiological information to the development of new technologies and statistical methods.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747002     DOI: 10.1016/s1474-4422(03)00663-x

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  107 in total

Review 1.  What do we know about the mechanism of action of disease-modifying treatments in MS?

Authors:  Hans-Peter Hartung; Amit Bar-Or; Yannis Zoukos
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

Review 2.  Heat shock protein 70: roles in multiple sclerosis.

Authors:  María José Mansilla; Xavier Montalban; Carmen Espejo
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

3.  DNA methylation signatures in development and aging of the human prefrontal cortex.

Authors:  Shusuke Numata; Tianzhang Ye; Thomas M Hyde; Xavier Guitart-Navarro; Ran Tao; Michael Wininger; Carlo Colantuoni; Daniel R Weinberger; Joel E Kleinman; Barbara K Lipska
Journal:  Am J Hum Genet       Date:  2012-02-02       Impact factor: 11.025

4.  Evidence that the Y chromosome influences autoimmune disease in male and female mice.

Authors:  Cory Teuscher; Rajkumar Noubade; Karen Spach; Benjamin McElvany; Janice Y Bunn; Parley D Fillmore; James F Zachary; Elizabeth P Blankenhorn
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-15       Impact factor: 11.205

5.  Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle.

Authors:  M T Kampman; T Wilsgaard; S I Mellgren
Journal:  J Neurol       Date:  2007-03-21       Impact factor: 4.849

6.  An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus.

Authors:  G C DeLuca; S V Ramagopalan; B M Herrera; D A Dyment; M R Lincoln; A Montpetit; M Pugliatti; M C N Barnardo; N J Risch; A D Sadovnick; M Chao; S Sotgiu; T J Hudson; G C Ebers
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-17       Impact factor: 11.205

Review 7.  From genes to function: the next challenge to understanding multiple sclerosis.

Authors:  Lars Fugger; Manuel A Friese; John I Bell
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

8.  IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients.

Authors:  Nicolas Couturier; Pierre-Antoine Gourraud; Isabelle Cournu-Rebeix; Claire Gout; Florence Bucciarelli; Gilles Edan; Marie-Claude Babron; Françoise Clerget-Darpoux; Michel Clanet; Bertrand Fontaine; David Brassat
Journal:  Eur J Hum Genet       Date:  2009-01-21       Impact factor: 4.246

9.  Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.

Authors:  Hüseyin Duyar; Jörn Dengjel; Katrien L de Graaf; Karl-Heinz Wiesmüller; Stefan Stevanović; Robert Weissert
Journal:  Immunogenetics       Date:  2005-02-12       Impact factor: 2.846

10.  Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.

Authors:  D R Booth; A T Arthur; S M Teutsch; C Bye; J Rubio; P J Armati; J D Pollard; R N S Heard; G J Stewart
Journal:  J Mol Med (Berl)       Date:  2005-08-02       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.